Evicenter
MarkdownMedical informationP&T meetings
Claseprubart (DNTH103)

Generalized myasthenia gravis

Launch
Not announced
Last updated
120 sources

Section 6 of 6

References

120 sources

  1. Alshekhlee et al. (2009) (opens in a new tab)
  2. ANZCTR ACTRN12622001265763 (opens in a new tab)
  3. ANZCTR ACTRN12624000352505 (opens in a new tab)
  4. Barnett-Tapia et al. (2026) (opens in a new tab)
  5. Beydoun et al. (2026) (opens in a new tab)
  6. Bkemv prescribing information (2026) (opens in a new tab)
  7. Bruckman et al. (2024) (opens in a new tab)
  8. Carr et al. (2010) (opens in a new tab)
  9. Cavalcante et al. (2024) (opens in a new tab)
  10. Choi et al. (2025) (opens in a new tab)
  11. Çipi et al. (2026) (opens in a new tab)
  12. Claytor et al. (2023) (opens in a new tab)
  13. ClinicalTrials.gov NCT06282159 (opens in a new tab)
  14. ClinicalTrials.gov NCT06858579 (opens in a new tab)
  15. ClinicalTrials.gov NCT07647510 (opens in a new tab)
  16. Dewilde et al. (2023a) (opens in a new tab)
  17. Dewilde et al. (2023b) (opens in a new tab)
  18. Dewilde et al. (2025a) (opens in a new tab)
  19. Dewilde et al. (2025b) (opens in a new tab)
  20. Dianthus Therapeutics (2022) (opens in a new tab)
  21. Dianthus Therapeutics (2023) (opens in a new tab)
  22. Dianthus Therapeutics (2024a) (opens in a new tab)
  23. Dianthus Therapeutics (2025b) (opens in a new tab)
  24. Dianthus Therapeutics (2025c) (opens in a new tab)
  25. Dianthus Therapeutics (2026c) (opens in a new tab)
  26. Dianthus Therapeutics (2026d) (opens in a new tab)
  27. Dianthus Therapeutics (2026g) (opens in a new tab)
  28. Dianthus Therapeutics Form 10-K (2025) (opens in a new tab)
  29. Dianthus Therapeutics Form 10-K (2026) (opens in a new tab)
  30. Dianthus Therapeutics Form 10-Q (2026c) (opens in a new tab)
  31. Dianthus Therapeutics Form 8-K (2026) (opens in a new tab)
  32. Dianthus Therapeutics presentation (2024a) (opens in a new tab)
  33. Dianthus Therapeutics presentation (2024b) (opens in a new tab)
  34. Dianthus Therapeutics presentation (2025a) (opens in a new tab)
  35. Dianthus Therapeutics presentation (2025b) (opens in a new tab)
  36. Dianthus Therapeutics presentation (2026a) (opens in a new tab)
  37. Dianthus Therapeutics presentation (2026c) (opens in a new tab)
  38. Dianthus Therapeutics presentation (2026e) (opens in a new tab)
  39. Dimachkie et al. (2026) (opens in a new tab)
  40. Dodd et al. (2025) (opens in a new tab)
  41. Dresser et al. (2021) (opens in a new tab)
  42. Epysqli prescribing information (2026) (opens in a new tab)
  43. EU Clinical Trials Information System 2026-525298-38-00 (opens in a new tab)
  44. Gelinas et al. (2022) (opens in a new tab)
  45. Gilhus et al. (2019) (opens in a new tab)
  46. Gilhus et al. (2024) (opens in a new tab)
  47. Gilhus et al. (2026) (opens in a new tab)
  48. Gokhale et al. (2024) (opens in a new tab)
  49. Grob et al. (2008) (opens in a new tab)
  50. Gronseth et al. (2020) (opens in a new tab)
  51. Grover et al. (2026a) (opens in a new tab)
  52. Grover et al. (2026b) (opens in a new tab)
  53. Habib et al. (2024) (opens in a new tab)
  54. Hehir and Silvestri (2018) (opens in a new tab)
  55. Herr et al. (2023) (opens in a new tab)
  56. Howard (2018) (opens in a new tab)
  57. Huang et al. (2024) (opens in a new tab)
  58. Hughes et al. (2023) (opens in a new tab)
  59. ICER (2021) (opens in a new tab)
  60. Imaavy prescribing information (2026) (opens in a new tab)
  61. Jackson et al. (2023) (opens in a new tab)
  62. Jackson et al. (2025) (opens in a new tab)
  63. Jacob et al. (2025) (opens in a new tab)
  64. Jaretzki et al. (2000) (opens in a new tab)
  65. Jiang et al. (2025) (opens in a new tab)
  66. Jul Jarbæk Nielsen et al. (2025) (opens in a new tab)
  67. Kaminski et al. (2024) (opens in a new tab)
  68. Khateb et al. (2025) (opens in a new tab)
  69. Kusner et al. (2012) (opens in a new tab)
  70. Landfeldt et al. (2020) (opens in a new tab)
  71. Li et al. (2026) (opens in a new tab)
  72. Lien et al. (2024) (opens in a new tab)
  73. Lord et al. (2026) (opens in a new tab)
  74. Manolopoulos et al. (2025) (opens in a new tab)
  75. Meisel et al. (2026) (opens in a new tab)
  76. Mestinon prescribing information (2023) (opens in a new tab)
  77. Muppidi et al. (2011) (opens in a new tab)
  78. Muppidi et al. (2022) (opens in a new tab)
  79. Myasthenia Gravis Foundation of America (opens in a new tab)
  80. Narayanaswami et al. (2021) (opens in a new tab)
  81. Narayanaswami et al. (2026) (opens in a new tab)
  82. Parthan et al. (2024) (opens in a new tab)
  83. Peric et al. (2026b) (opens in a new tab)
  84. Peric et al. (2026c) (opens in a new tab)
  85. Peric et al. (2026e) (opens in a new tab)
  86. Pesa et al. (2026a) (opens in a new tab)
  87. Pesa et al. (2026b) (opens in a new tab)
  88. Phillips et al. (2022) (opens in a new tab)
  89. Rodrigues et al. (2024) (opens in a new tab)
  90. Rousseff (2021) (opens in a new tab)
  91. Rystiggo prescribing information (2025) (opens in a new tab)
  92. Salari et al. (2021) (opens in a new tab)
  93. Sanders et al. (2016) (opens in a new tab)
  94. Sciancalepore et al. (2025) (opens in a new tab)
  95. Shelly et al. (2026) (opens in a new tab)
  96. Siddiqi et al. (2025) (opens in a new tab)
  97. Silvestri et al. (2026) (opens in a new tab)
  98. Smith et al. (2026) (opens in a new tab)
  99. Soliris prescribing information (2026) (opens in a new tab)
  100. Suzuki et al. (2026) (opens in a new tab)
  101. Tice et al. (2022) (opens in a new tab)
  102. Ultomiris prescribing information (2026) (opens in a new tab)
  103. Uplizna prescribing information (2025) (opens in a new tab)
  104. Vinciguerra et al. (2023) (opens in a new tab)
  105. Vissing et al. (2020) (opens in a new tab)
  106. Vissing et al. (2024) (opens in a new tab)
  107. Vu et al. (2026a) (opens in a new tab)
  108. Vu et al. (2026b) (opens in a new tab)
  109. Vyvgart Hytrulo prescribing information (2026) (opens in a new tab)
  110. Vyvgart prescribing information (2026) (opens in a new tab)
  111. WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (2026) (opens in a new tab)
  112. WHO Drug Information Recommended INN List 94 (2025) (opens in a new tab)
  113. WHO INN monoclonal antibody nomenclature scheme (2022) (opens in a new tab)
  114. WHO Proposed INN List 132 (2024) (opens in a new tab)
  115. Wolfe et al. (2016) (opens in a new tab)
  116. Wolfe et al. (2019) (opens in a new tab)
  117. Ye et al. (2024) (opens in a new tab)
  118. Yoder et al. (2025) (opens in a new tab)
  119. Zhdanava et al. (2024) (opens in a new tab)
  120. Zilbrysq prescribing information (2026) (opens in a new tab)